Ahmed Salih

Patient Outcomes In Those Diagnosed With Multiple Myeloma Over A 5-Year Period In India

Introduction:Multiple myeloma (MM) is the second most common hematological malignancy worldwide. The treatment of MM is induction therapy followed by an autologous stem cell transplant (A...

Ahmed Salih ;

Sasmith R. Menakuru ;

Amir F. Beirat ;

Vijaypal Dhillon ;

11/04/2022

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

March 27 ⁠–⁠ March 30

See Full Calendar

Ahmed Salih

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products